Wisconsin Assembly Republicans held a press conference Sept. 7 at the Capitol to announce their “Forward Agenda.” A glossy 30-page booklet begins with this definition:
“The Forward Agenda is a broad outline of goals for the 2017-18 legislative session and beyond. We believe that less government is good government, one that fosters an environment for job growth. This agenda has three sections: improving the economy, expanding opportunities, and building strong families and safe communities.”
Deep within on Page 24 under the heading, “Health and Public Safety,” there is a reference to CBD Oil.
In 2014, the legislature took an important step in allowing access to non-psychoactive Cannabidiol Oil to those struggling with seizure disorders. However, it has since been seen that those individuals are still not able to access this treatment due to the red tape still associated with it. Assembly Republicans will look to address this issue so that those who face seizure disorders are finally able to access an important treatment option originally intended by the initial bill passed by the legislature.
The Republican-sponsored 2015-2016 CBD bill AB228/SB221, passed out of committee in both houses, passed the Assembly but then was killed by GOP Senate Majority Leader Scott Fitzgerald by adjourning the Senate before a motion could be voted on to bring it to the floor in the last session of the year. Fitzgerald later said that three Republican senators, Senate President Mary Lazich (R-New Berlin) along with Duey Stroebel (R-Cedarburg) and Leah Vukmir (R-Wauwatosa), had adamantly opposed the bill out of concerns it could lead to the legalization of marijuana in Wisconsin. “I understand why people would be frustrated because, from the outside looking in, it probably doesn’t make much sense,” Fitzgerald told the Milwaukee Journal Sentinel at the time.
Right below the CBD Oil section on the left on the same page is another health-related statement:
Right to Try
Access to varying healthcare options and solutions are key when trying to make the best decision for you and your family. Assembly Republicans will investigate options for terminally ill individuals to have easier access to experimental therapies, because for those diagnosed with a terminal illness, every day and every option available to them counts.
Kind of ironic that a legislative majority that rejects whole plant cannabis for any qualifying state patient in favor of CBD-only cannabis mainly for children with seizure disorders is saying such things. As long as it’s synthetic, it’s apparently a go, safety concerns or not. But for those who can find proven relief from whole plant cannabis, ideology has again overruled common sense. Right To Try should include all therapeutic agents, not all but one, a plant with well-documented medical use.